Simplified criteria for the diagnosis of autoimmune hepatitis

Hepatology

Volumn 48, Issue 1, 2008, Pages 169-176

  Hennes, Elke M ^a   Zeniya, Mikio ^b   Czaja, Albert J ^c   Parés, Albert ^d   Dalekos, George N ^e   Krawitt, Edward L ^f   Bittencourt, Paulo L ^g   Porta, Gilda ^g   Boberg, Kirsten M ^h   Hofer, Harald ⁱ   Bianchi, Francesco B ^j   Shibata, Minoru ^k   Schramm, Christoph ^a   De Torres, Barbara Eisenmann ^l   Galle, Peter R ^l   McFarlane, Ian ^m   Dienes, Hans Peter ⁿ   Lohse, Ansgar W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JIKEI University Graduate School of Medicine   (Japan)

^c MAYO CLINIC   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITY OF THESSALY   (Greece)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k NTT CORPORATION   (Japan)

^l JOHANNES GUTENBERG UNIVERSITY   (Germany)

^m KING S COLLEGE HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G;

ADULT; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AREA UNDER CURVE; COHORT STUDIES; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; GASTROENTEROLOGY; HEPATITIS, AUTOIMMUNE; HUMANS; INTERNATIONAL COOPERATION; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 47149112922     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22322     Document Type: Article

References (35)

1. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99-103.
2. Kanzler S, Lohr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001;39:339-341, 344-348.
3. Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972;63:820-833.
4. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68:253-256.
5. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980;21:78-83.
6. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. HEPATOLOGY 2005;42:53-62.
7. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
8. Schramm C, Kanzler S, zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001;96:1587-1591.
9. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006;45:575-583.
10. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. HEPATOLOGY 1993;18:998-1005.
11. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
12. Dienes HP, Erberich H, Dries V, Schirmacher P, Lohse A. Autoimmune hepatitis and overlap syndromes. Clin Liver Dis 2002;6:349-62, vi.
13. Czaja AJCHA. Autoimmune hepatitis. In: McSween R, ed. Pathology of the liver. 5th ed. New York: Churchill Livingstone, 2007.
14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 1988;44:837-845.
15. Vergani D, Alvarez F, Bianchi FB, Cancado ELR, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683.
16. Chretien-Leprince P, Ballot E, Andre C, Olsson NO, Fabien N, Escande A, et al. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann N Y Acad Sci 2005;1050:266-273.
17. Frenzel C, Herkel J, Luth S, Galle PR, Schramm C, Lohse AW. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006;101:2731-2736.
18. Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002;51:259-264.
19. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000;355:1510-1515.
20. Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. HEPATOLOGY 2002;35:403-408.
21. Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. HEPATOLOGY 2002;35:658-664.
22. Lohse AW, Gerken G, Mohr H, Lohr HF, Treichel U, Dienes HP, et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z.Gastroenterol 1995;33:527-533.
23. Denzer U, Helmreich-Becker I, Galle PR, Lohse AW. Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding. Am.J.Gastroenterol 2003;98:893-900.
24. Shin JL, Teitel J, Swain MG, Bain V G, Adams P C, Croitoru K, et al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful? Am.J Hematol 2005;78:85-93.
25. Sawyerr AM, McCormick PA, Tennyson GS, Chin J, Dick R, Scheuer PJ, et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol 1993;17:81-85.
26. Lohse AW, Gerken G, Meyer zum Buschenfelde KH. Autoimmune hepatitis and hepatitis C virus infection. Curr Stud Hematol Blood Transfus 1994;89-97.
27. Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-314.
28. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, et al. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis: an Italian experience. Dig Dis Sci 1996;41:166-171.
29. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan: correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997;26:1207-1212.
30. Miyakawa H, Kitazawa E, Abe K, Kawaguchi N, Fuzikawa H, Kikuchi K, et al. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol 1997;32:769-776.
31. Dickson RC, Gaffey MJ, Ishitani MB, Roarty TP, Driscoll CJ, Caldwell SH. The international autoimmune hepatitis score in chronic hepatitis C. J Viral Hepatol 1997;4:121-128.
32. van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000;33:543-548.
33. Omagari K, Masuda J, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, et al. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Intern Med 2000;39:1008-1012.
34. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 2000;33:537-542.
35. Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG, Kypri L, et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 2007;4:3.